PenderFund Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

PenderFund Capital Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,250	Closed	-$920K	–	152
2023 Q1	$920K	Buy	+28,250	New	+$355K	0.29%	59

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

PenderFund Capital Management's PRVB Position: Q2 2023 in Review

PenderFund Capital Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 28,250 shares — an estimated $920K sold.

PenderFund Capital Management first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $920K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

PenderFund Capital Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
PenderFund Capital Management sold 28,250 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $920K.
PenderFund Capital Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
PenderFund Capital Management's Provention Bio, Inc. Common Stock position peaked at $920K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on PenderFund Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.